Xudong Fu

机构：Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou People's Hospital, Hubei University of Technology · ORCID：0000-0002-3412-535X

发表论文 53 篇 · 总被引 505 次 · h-index 14

代表论文

• Emerging roles of suppressor of cytokine signaling 3 in human cancers (2021 · Biomedicine & Pharmacotherapy · 被引 53)
• SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer (2022 · Frontiers in Oncology · 被引 33)
• Loss of FBXW7 Correlates with Increased IDH1 Expression in Glioma and Enhances IDH1-Mutant Cancer Cell Sensitivity to Radiation (2021 · Cancer Research · 被引 27)
• Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma (2022 · Frontiers in Cell and Developmental Biology · 被引 24)
• The role of ubiquitin-specific peptidases in glioma progression (2021 · Biomedicine & Pharmacotherapy · 被引 20)
• HLA‐DR⁺ Tumor Cells Show an Association with a Distinct Immune Microenvironment and CD8⁺ T‐Cell Exhaustion in HBV‐Associated Hepatocellular Carcinoma (2025 · Advanced Science · 被引 11)